Prevalence of gastric precancerous conditions: A systematic review and meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 4, 2014, Pages 378-387

  Marques Silva, Luís ^a   Areia, Miguel ^b,d   Elvas, Luís ^d   Dinis Ribeiro, Mário ^a,b,c  

^a CIDES   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^d Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

Author keywords

atrophic gastritis; gastric cancer; gastric neoplasm; gastrointestinal endoscopy; Helicobacter pylori; intestinal metaplasia; meta analysis; pepsinogens; review; stomach neoplasm

Indexed keywords

ARTICLE; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER RISK; CHRONIC ATROPHIC GASTRITIS; CHRONIC DISEASE; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; INTESTINE METAPLASIA; META ANALYSIS; POPULATION; PRECANCER; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STOMACH BIOPSY; STOMACH CANCER; SYSTEMATIC REVIEW;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGE FACTORS; BIOPSY; FEMALE; GASTROSCOPY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STOMACH NEOPLASMS;

EID: 84896396977     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000065     Document Type: Article

References (132)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
2. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48:3554-3560.
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
4. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-1181. (Pubitemid 26336840)
5. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16:1249-1259.
6. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56:631-636. (Pubitemid 46662927)
7. Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71:1150-1158.
8. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44:74-94.
9. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1-241.
10. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168:219-221. (Pubitemid 23178754)
11. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
12. Lahner E, Vaira D, Figura N, Pilozzi E, Pasquali A, Severi C, et al. Role of noninvasive tests (C-urea breath test and stool antigen test) as additional tools in diagnosis of Helicobacter pylori infection in patients with atrophic body gastritis. Helicobacter 2004; 9:436-442. (Pubitemid 39273948)
13. Areia M, Amaro P, Dinis-Ribeiro M, Cipriano MA, Marinho C, Costa-Pereira A, et al. External validation of a classification for methylene blue magnification chromoendoscopy in premalignant gastric lesions. Gastrointest Endosc 2008; 67:1011-1018. (Pubitemid 351728107)
14. Areia M, Amaro P, Dinis-Ribeiro M, Moreira-Dias L, Romaozinho JM, Gouveia H, et al. Estimation of the extent of gastric intestinal metaplasia by methylene blue chromoendoscopy. Eur J Gastroenterol Hepatol 2008; 20:939-940.
15. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93:1090-1096. (Pubitemid 29080956)
16. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15:885-891. (Pubitemid 36904458)
17. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004; 6:449-456. (Pubitemid 39411081)
18. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11:141-147. (Pubitemid 39274096)
19. Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Vieira AS, Bento MJ, Lomba-Viana H. Serum pepsinogen test for early detection of gastric cancer in a European country. Eur J Gastroenterol Hepatol 2012; 24:37-41.
20. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Moreira-Dias L. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2007; 22:1594-1604. (Pubitemid 47383332)
21. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Guilherme M, Barbosa J, Lomba-Viana H, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol 2004; 57:177-182. (Pubitemid 38177758)
22. Areia M, Carvalho R, Cadime AT, Rocha Goncalves F, Dinis-Ribeiro M. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter 2013; 18:325-337.
23. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006; 15: 1083-1094.
24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62:1006-1012.
25. Areia M, Soares M, Dinis-Ribeiro M. Quality reporting of endoscopic diagnostic studies in gastrointestinal journals: where do we stand on the use of the STARD and CONSORT statements? Endoscopy 2010; 42:138-147.
26. Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and Forest plots using a Microsoft Excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes 2012; 5:52.
27. Alina B, Daniela D, Ofelia P, Simona M. The detection of premalignant and malignant gastric lesions by conventional endoscopy in a general population sample. Acta Medica Marisiensis 2011; 57:136-141.
28. Al-Knawy B, Morad N, Jamal A, Mirdad S, Fotouh MA, Ahmed ME, et al. Helicobacter pylori and intestinal metaplasia with its subtypes in the gastric antrum in a Saudi population. Scand J Gastroenterol 1999; 34:562-565. (Pubitemid 29339208)
29. Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Koshiyama H, et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1996; 1:52-56. (Pubitemid 126671075)
30. Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 2001; 6:294-299. (Pubitemid 34015010)
31. Bodger K, Wyatt JI, Heatley RV. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 2001; 6: 216-224. (Pubitemid 32843605)
32. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F. Eurohepygast Study G. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003; 88:1239-1247. (Pubitemid 36606340)
33. Burr ML, Samloff IM, Bates CJ, Holliday RM. Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates. Br J Cancer 1987; 56:163-167. (Pubitemid 17155532)
34. Campbell DI, Warren BF, Thomas JE, Figura N, Telford JL, Sullivan PB. The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter 2001; 6:263-267. (Pubitemid 34015006)
35. Carrilho C, Modcoicar P, Cunha L, Ismail M, Guisseve A, Lorenzoni C, et al. Prevalence of Helicobacter pylori infection, chronic gastritis, and intestinal metaplasia in Mozambican dyspeptic patients. Virchows Arch 2009; 454:153-160.
36. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000; 95:1431-1438. (Pubitemid 30396299)
37. Chang CH, Wu MS, Chang YT, Chang MC, Shun CT, Liu CY, et al. Risk factors for intestinal metaplasia in adult residents of Matzu: a crosssectional study. J Formos Med Assoc 2002; 101:835-840.
38. Cheli R, Simon L, Aste H, Figus IA, Nicolo G, Bajtai A, et al. Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations. Endoscopy 1980; 12:105-108. (Pubitemid 10109608)
39. Chen XY, van Der Hulst RW, Shi Y, Xiao SD, Tytgat GN, Ten Kate FJ. Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients. J Clin Pathol 2001; 54:367-370. (Pubitemid 32458134)
40. Con SA, Con-Wong R, Con-Chin GR, Con-Chin VG, Takeuchi H, Valerin AL, et al. Serum pepsinogen levels, Helicobacter pylori CagA status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Cancer Epidemiol Biomarkers Prev 2007; 16:2631-2636. (Pubitemid 351196318)
41. Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990; 50:4731-4736. (Pubitemid 20230421)
42. Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 1992; 33:597-600.
43. Den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer 2011; 47:1211-1218.
44. Derakhshan MH, El-Omar E, Oien K, Gillen D, Fyfe V, Crabtree JE, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 2006; 59:1293-1299. (Pubitemid 46048335)
45. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118: 22-30. (Pubitemid 30020369)
46. Emura F, Mejý́a J, Mejý́a M, Osorio C, Hernández C, Gonzá lez I, et al. Effectiveness of systematic chromoendoscopy for diagnosis of early cancer and gastric premalignant lesions. Results of two consecutive screening campaigns in Colombia (2006-2007). Rev Col Gastroenterol 2010; 25:19-30.
47. Eriksson NK, Karkkainen PA, Farkkila MA, Arkkila PE. Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 2008; 40:355-360.
48. Eshmuratov A, Nah JC, Kim N, Lee HS, Lee HE, Lee BH, et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci 2010; 55:1364-1375.
49. Fennerty MB, Emerson JC, Sampliner RE, McGee DL, Hixson LJ, Garewal HS. Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev 1992; 1:293-296.
50. Fraser AG, Peng SL, Jass JR. Intestinal metaplasia subtypes and Helicobacter pylori infection: a comparison of ethnic groups in New Zealand. J Gastroenterol Hepatol 1998; 13:560-565. (Pubitemid 28407296)
51. Fukao A, Komatsu S, Tsubono Y, Hisamichi S, Ohori H, Kizawa T, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993; 4:307-312. (Pubitemid 23205740)
52. Germaná B, Di Mario F, Cavallaro LG, Moussa AM, Lecis P, Liatoupolou S, et al. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care. Dig Liver Dis 2005; 37:501-508. (Pubitemid 44356059)
53. Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, Guerrero L, et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 2006; 4:306-314. (Pubitemid 43343886)
54. Green TJ, Venn BJ, Skeaff CM, Williams SM. Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders. Eur J Clin Nutr 2005; 59:205-210. (Pubitemid 40268315)
55. Guarner J, Herrera-Goepfert R, Mohar A, Sanchez L, Halperin D, Ley C, et al. Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients. Hum Pathol 2001; 32:31-35. (Pubitemid 32150625)
56. Guarner J, Herrera-Goepfert R, Mohar A, Smith C, Schofield A, Halperin D, et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol 2003; 34:28-31. (Pubitemid 36160018)
57. Guarner J, Mohar A, Parsonnet J, Halperin D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 1993; 71:297-301. (Pubitemid 23021211)
58. Hartleb M, Wandzel P, Waluga M, Matyszczyk B, Boldys H, Romanczyk T. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastroenterol Belg 2004; 67:320-326. (Pubitemid 40188052)
59. Haziri A, Juniku-Shkololli A, Gashi Z, Berisha D. Helicobacter pylori infection and precancerous lesions of the stomach. Med Arh 2010; 64:248-249.
60. Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009; 15:853-859.
61. Inoue K, Fujisawa T, Haruma K. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers 2010; 25:207-212.
62. Inoue M, Kobayashi S, Matsuura A, Hamajima N, Tajima K, Tominaga S. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1998; 7:261-263. (Pubitemid 28353939)
63. Ito LS, Oba-Shinjo SM, Marie SK, Uno M, Shinjo SK, Hamajima N, et al. Lifestyle factors associated with atrophic gastritis among Helicobacter pylori-seropositive Japanese-Brazilians in Sao Paulo. Int J Clin Oncol 2003; 8:362-368. (Pubitemid 38036092)
64. Ito Y, Suzuki K. The effect of serum carotenoids on atrophic gastritis among the inhabitants of a rural area in Hokkaido, Japan. Environ Health Prev Med 2001; 6:184-188. (Pubitemid 33031658)
65. Jonaitis L, Ivanauskas A, Janciauskas D, Funka K, Sudraba A, Tolmanis I, et al. Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients. Medicina (Kaunas) 2007; 43:623-629.
66. Kang KP, Lee HS, Nayoung K, Kang HM, Park YS, Lee DH, et al. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol 2009; 24:140-148.
67. Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34:1032-1037. (Pubitemid 23245349)
68. Kato I, Vivas J, Plummer M, Lopez G, Peraza S, Castro D, et al. Environmental factors in Helicobacter pylori-related gastric precancerous lesions in Venezuela. Cancer Epidemiol Biomarkers Prev 2004; 13: 468-476. (Pubitemid 38737474)
69. Kato S, Nakajima S, Nishino Y, Ozawa K, Minoura T, Konno M, et al. Association between gastric atrophy and Helicobacter pylori infection in Japanese children: a retrospective multicenter study. Dig Dis Sci 2006; 51:99-104. (Pubitemid 43106344)
70. Khamehchian T, Sharifi H, Mazuchi T, Talari SA. Frequency of precancerous lesions in stomach of patients. J Med Sci 2006; 6:666-669. (Pubitemid 44613188)
71. Kikuchi R, Abe Y, Iijima K, Koike T, Ara N, Uno K, et al. Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer. Tohoku J Exp Med 2011; 223:35-44.
72. Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003; 38:332-338. (Pubitemid 36626268)
73. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345:1525-1528.
74. Kuwahara Y, Kono S, Eguchi H, Hamada H, Shinchi K, Imanishi K. Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men. Scand J Gastroenterol 2000; 35:476-481. (Pubitemid 30354086)
75. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, et al. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Dig Dis Sci 2009; 54: 2377-2384.
76. Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, et al. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Eur J Gastroenterol Hepatol 2012; 24:1410-1417.
77. Leodolter A, Ebert MP, Peitz U,Wolle K, Kahl S, Vieth M, et al. Prevalence of H. pylori associated 'high risk gastritis' for development of gastric cancer in patients with normal endoscopic findings. World J Gastroenterol 2006; 12:5509-5512. (Pubitemid 44501810)
78. Leung WK, Ng EK, Chan WY, Auyeung AC, Chan KF, Lam CC, et al. Risk factors associated with the development of intestinal metaplasia in firstdegree relatives of gastric cancer patients. Cancer Epidemiol Biomarkers Prev 2005; 14:2982-2986. (Pubitemid 43068834)
79. Ley C, Mohar A, Guarner J, Herrera-Goepfert R, Figueroa LS, Halperin D, et al. Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 2004; 13:4-10. (Pubitemid 38116614)
80. Liu C-Y, Wu C-Y, Lin J-T, Lee Y-C, Yen AM-F Chen TH-H. Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer. J Med Screen 2006; 13:2-5.
81. Liu J, Sun LP, Gong YH, Yuan Y. Risk factors of precancerous gastric lesions in a population at high risk of gastric cancer. Chin J Cancer Res 2010; 22:267-273.
82. Lombardo L, Leto R, Molinaro G, Migliardi M, Ravarino N, Rocca R, et al. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test. Clin Chem Lab Med 2010; 48:1327-1332.
83. Maaroos HI, Vorobjova T, Sipponen P, Tammur R, Uibo R,Wadstrom T, et al. An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol 1999; 34:864-869. (Pubitemid 29470563)
84. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol 2004; 57:37-42. (Pubitemid 38091308)
85. Micu G, Staniceanu F, Zurac S, Popp C, Bastian A, Gramada E, et al. Regression of precancerous epithelial alteration in patients with Helicobacter pylori chronic gastritis. Rom J Intern Med 2010; 48:89-99.
86. Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, et al. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci 2010; 55:3132-3137.
87. Motta CR, MP Cunha, Queiroz DM, Cruz FW, Guerra EJ, Mota RM, et al. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from northeastern Brazil. Digestion 2008; 78:3-8.
88. Muller LB, Fagundes RB, Moraes CC, Rampazzo A. Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia. Arq Gastroenterol 2007; 44:93-98. (Pubitemid 350021930)
89. Munoz N, Kato I, Peraza S, Lopez G, Carrillo E, Ramirez H, et al. Prevalence of precancerous lesions of the stomach in Venezuela. Cancer Epidemiol Biomarkers Prev 1996; 5:41-46.
90. Namekata T, Miki K, Kimmey M, Fritsche T, Hughes D, Moore D, et al. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle. Am J Epidemiol 2000; 151:820-830. (Pubitemid 30461146)
91. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109:138-143. (Pubitemid 38160674)
92. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134:380-386. (Pubitemid 32179477)
93. Okada M, Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, et al. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2000; 15:1105-1112.
94. Ozdil K, Sahin A, Kahraman R, Yuzbasioglu B, Demirdag H, Calhan T, et al. Current prevalence of intestinal metaplasia and Helicobacter pylori infection in dyspeptic adult patients from Turkey. Hepatogastroenterology 2010; 58:1563-1566.
95. Pasechnikov V, Chukov S, Kotelevets S, Mostovov A, Mernova V, Polyakova M. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scand J Gastroenterol 2005; 40:297-301. (Pubitemid 40476460)
96. Peleteiro B, Lunet N, Figueiredo C, Carneiro F, David L, Barros H. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiol Biomarkers Prev 2007; 16: 322-326. (Pubitemid 46383353)
97. Petersson F, Borch K, Franzen LE. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol 2002; 37:262-266. (Pubitemid 34201776)
98. Plummer M, van Doorn LJ, Franceschi S, Kleter B, Canzian F, Vivas J, et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 2007; 99:1328-1334. (Pubitemid 47394171)
99. Quach DT, Le HM, Nguyen OT, Nguyen TS, Uemura N. The severity of endoscopic gastric atrophy could help to predict operative link on gastritis assessment gastritis stage. J Gastroenterol Hepatol 2011; 26:281-285.
100. Recavarren-Arce S, Gilman RH, LeonBarua R, Salazar G, McDonald J, Lozano R, et al. Chronic atrophic gastritis: early diagnosis in a population where Helicobacter pylori infection is frequent. Clin Infect Dis 1997; 25:1006-1012. (Pubitemid 27513175)
101. Redeen S, Petersson F, Kechagias S, Mardh E, Borch K. Natural history of chronic gastritis in a population-based cohort. Scand J Gastroenterol 2010; 45:540-549.
102. Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004; 99:1910-1915. (Pubitemid 39421232)
103. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HMT. Atrophic gastritis in young children and adolescents. J Clin Pathol 2005; 58:1189-1193. (Pubitemid 41566465)
104. Rojas-Ló pez V, Garza-Gonzá lez E, Fuentes-de la Fuente HA, Galvá n-Castro P, Flores-Gutié rrez JP, González- Gonzá lez JA, et al. Non-invasive diagnosis of atrophic gastritis in dyspeptic adult patients. Medicina Universitaria 2011; 13:31-36.
105. Rollan A, Ferreccio C, Gederlini A, Serrano C, Torres J, Harris P. Noninvasive diagnosis of gastric mucosal atrophy in an asymptomatic population with high prevalence of gastric cancer. World J Gastroenterol 2006; 12:7172-7178. (Pubitemid 44890649)
106. Rothery GA, Day DW. Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa. J Clin Pathol 1985; 38:613-621. (Pubitemid 15050381)
107. Rugge M, De Boni M, Pennelli G, De Bona M, Giacomelli L, Fassan M, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinicopathological follow-up study. Aliment Pharmacol Ther 2010; 31: 1104-1111.
108. Russo A, Maconi G, Spinelli P, Di Felice G, Eboli M, Andreola S, et al. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol 2001; 96:1402-1408. (Pubitemid 32455066)
109. Sakitani K, Hirata Y, Watabe H, Yamada A, Sugimoto T, Yamaji Y, et al. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol 2011; 26:1570-1575.
110. Salazar CR, Francois F, Li Y, Corby P, Hays R, Leung C, et al. Association between oral health and gastric precancerous lesions. Carcinogenesis 2012; 33:399-403.
111. Sato K, Kawakami N, Ohtsu T, Tsutsumi A, Miyazaki S, Masumoto T, et al. Broccoli consumption and chronic atrophic gastritis among Japanese males: an epidemiological investigation. Acta Med Okayama 2004; 58:127-133. (Pubitemid 38981232)
112. Shibata A, Hamajima N, Ikehara Y, Saito T, Matsuo K, Katsuda N, et al. ABO blood type, Lewis and Secretor genotypes, and chronic atrophic gastritis: a cross-sectional study in Japan. Gastric Cancer 2003; 6:8-16. (Pubitemid 36460551)
113. Shibata K, Moriyama M, Fukushima T, Kaetsu A, Miyazaki M, Une H. Green tea consumption and chronic atrophic gastritis: a cross-sectional study in a green tea production village. J Epidemiol 2000; 10:310-316.
114. Sierra R, Une C, Ram?́rez V, Gonzá lez M, Ram?́rez J, Mascarel A, et al. Association of serum pepsinogen with atrophic body gastritis in Costa Rica. Clin Exp Med 2006; 6:72-78.
115. Sitas F, Smallwood R, Jewell D, Millard PR, Newell DG, Meuwissen SG, et al. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1993; 2:119-123.
116. Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, et al. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol 1998; 93:375-379. (Pubitemid 29068340)
117. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008; 43:1448-1455.
118. Tahara T, Shibata T, Nakamura M, Yoshioka D, Okubo M, Arisawa T, et al. Gastric mucosal pattern by using magnifying narrow-band imaging endoscopy clearly distinguishes histological and serological severity of chronic gastritis. Gastrointest Endosc 2009; 70:246-253.
119. Telaranta-Keerie A, Kara R, Paloheimo L, Hrknen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4256 volunteers without specific complaints. Scand J Gastroenterol 2010; 45:1036-1041.
120. Tsukanov VV, Butorin NN, Maady AS, Shtygasheva OV, Amelchugova OS, Tonkikh JL, et al. Helicobacter pylori infection, intestinal metaplasia, and gastric cancer risk in eastern Siberia. Helicobacter 2011; 16:107-112.
121. Vázquez Romero M, Boixeda de Miguel D, Valer Ló pez-Fando MP, Albé niz Arbizu E, Gonzá lez Alonso R, Bermejo S. J. F. Intestinal metaplasia: evolution after Helicobacter pylori eradication and influence in the success of eradicating therapy. Rev Esp Enferm Dig 2003; 95:777-784.
122. Watabe H, Mitsushima T, Derakhshan MH, Yamaji Y, Okamoto M, Kawabe T, et al. Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10 197 Japanese subjects. Dig Dis Sci 2009; 54:988-995.
123. Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population-based study among 9444 older adults from Germany. Aliment Pharmacol Ther 2007; 26:879-887. (Pubitemid 47346707)
124. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50:378-381. (Pubitemid 34161055)
125. Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, et al. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Dig Dis 2004; 5:22-27. (Pubitemid 38401246)
126. Xia HH, Kalantar JS, Talley NJ, Wyatt JM, Adams S, Chueng K, et al. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia? Am J Gastroenterol 2000; 95:114-121. (Pubitemid 30041544)
127. Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, et al. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 2008; 17:838-845. (Pubitemid 351536414)
128. Yee YK,Wong KW, Hui CK, Chan CK, Chan AO, Lam SK, et al. Prevalence and time trend of intestinal metaplasia in Hong Kong. J Gastroenterol Hepatol 2009; 24:896-899.
129. Yeh LY, Raj M, Hassan S, Aziz SA, Othman NH, Mutum SS, et al. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian J Gastroenterol 2009; 28:49-52.
130. You WC, Zhang L, Gail MH, Li JY, Chang YS, Blot WJ, et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998; 27:945-948. (Pubitemid 29026742)
131. Zhang YL, Lai ZS, Zhou DY, Yamada N, Wen M. Supra-angular biopsy is more reliable for atrophy recognization: analysis of 1598 cases for gastric mucosal histological examination. World J Gastroenterol 2000; 6: 893-897. (Pubitemid 32015809)
132. Areia M, Pimentel-Nunes P, Marcos-Pinto R, Dinis-Ribeiro M. Gastric cancer: an opportunity for prevention. Acta Med Port 2013; 26:627-629.